Showing 361-370 of 708 results for "".
Psoriasis in Sensitive Areas
https://practicaldermatology.com/topics/psoriasis/psoriasis-in-sensitive-areas/23868/Treatment updates and tips for communicating with patients.Stoking the Embers: Re-exploring Topical Coal Products
https://practicaldermatology.com/columns/clinical-focus-1/stoking-the-embers-re-exploring-topical-coal-products/23825/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20693/News
https://practicaldermatology.com/topics/practice-management/news/21202/Erythema Multiforme Major Due to Fluconazole: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/erythema-multiforme-major-due-to-fluconazole-a-case-report/23887/Manage and Prevent Isotretinoin Side Effects
https://practicaldermatology.com/topics/general-topics/PD0409_01-php/22839/This guide will help you anticipate and prevent or minimize side effects that your patients can develop as a result of isotretinoin therapy.Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
https://practicaldermatology.com/programs/cme/data-driving-recent-guideline-updates-in-neoadjuvant-therapy-for-resectable-melanoma/36322/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
https://practicaldermatology.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-braf-mutant-stage-iv-melanoma/36328/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://practicaldermatology.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
https://practicaldermatology.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.